Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 First Patient Enrolled in Clinical Trial to Test Gore Aneurysm Technology - Medical Product Outsourcing

First Patient Enrolled in Clinical Trial to Test Gore Aneurysm Technology

The device already has CE mark in Europe.

The first patient has been enrolled in the Gore Excluder iliac branch clinical study, a prospective, multi-center, non-randomized, single-arm study designed to assess the safety and effectiveness of the Gore Excluder Iliac branch endoprosthesis made by Flagstaff, Ariz.-based W.L. Gore & Associates for treatment of patients with common iliac artery aneurysms or aorto-iliac aneurysms.

The patient was treated at St. Anthony’s Medical Center, in St. Louis, Mo., by Brian Peterson, M.D., from Saint Louis University.

The Gore Excluder devices (iliac branch component and internal iliac component) are used in conjunction with the Gore Excluder AAA endoprosthesis to isolate the common iliac artery from systemic blood flow and preserve blood flow in the external iliac and internal iliac arteries.

Peterson said: “We are pleased to get this important study underway and move closer toward improved iliac artery repair. The low-profile design, pre-cannulated branch, and bi-femoral delivery system proved beneficial in this first case. We look forward to the results of this important study and their implications for minimally invasive endovascular procedures involving iliac arteries.”

“Providing the best possible patient care and fulfilling unmet clinical needs require constant innovation. Gore is committed to advancing these innovations through collaboration with the clinical community,” added Ryan Takeuchi, head of Gore’s Aortic business unit. “We are excited that endovascular specialists globally are expressing such a high level of interest in the study and in iliac artery repair solutions.”

Endovascular specialists will enroll 60 patients at up to 50 sites during the course of this study. The Gore Excluder Iliac branch endoprosthesis received CE mark in October and is currently available in the U.S. for investigational purposes only.

Gore’s products includes vascular grafts, endovascular and interventional devices, surgical meshes for hernia repair, soft-tissue reconstruction, staple line reinforcement and sutures for use in vascular, cardiac, and general surgery.

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters